Comparing Consort Medical (CSRMY) and Its Peers

Consort Medical (OTCMKTS: CSRMY) is one of 26 public companies in the “Surgical appliances & supplies” industry, but how does it compare to its competitors? We will compare Consort Medical to similar companies based on the strength of its earnings, profitability, analyst recommendations, dividends, risk, institutional ownership and valuation.

Analyst Ratings

This is a summary of current ratings and price targets for Consort Medical and its competitors, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Consort Medical 0 0 0 0 N/A
Consort Medical Competitors 125 705 1253 52 2.58



As a group, “Surgical appliances & supplies” companies have a potential upside of 0.73%. Given Consort Medical’s competitors higher possible upside, analysts plainly believe Consort Medical has less favorable growth aspects than its competitors.

Profitability

This table compares Consort Medical and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Consort Medical N/A N/A N/A
Consort Medical Competitors -295.29% -52.73% -18.42%

Valuation and Earnings

This table compares Consort Medical and its competitors top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Consort Medical $380.46 million $29.23 million 18.84
Consort Medical Competitors $1.33 billion $194.17 million 23.35

Consort Medical’s competitors have higher revenue and earnings than Consort Medical. Consort Medical is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Risk and Volatility

Consort Medical has a beta of 0.1, indicating that its share price is 90% less volatile than the S&P 500. Comparatively, Consort Medical’s competitors have a beta of 0.84, indicating that their average share price is 16% less volatile than the S&P 500.

Dividends

Consort Medical pays an annual dividend of $0.24 per share and has a dividend yield of 1.5%. Consort Medical pays out 28.9% of its earnings in the form of a dividend. As a group, “Surgical appliances & supplies” companies pay a dividend yield of 1.3% and pay out 27.8% of their earnings in the form of a dividend.

Insider & Institutional Ownership

54.5% of shares of all “Surgical appliances & supplies” companies are held by institutional investors. 11.2% of shares of all “Surgical appliances & supplies” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Consort Medical competitors beat Consort Medical on 7 of the 11 factors compared.

Consort Medical Company Profile

Consort Medical PLC is a contract development and manufacturing organization (CDMO). The Company’s principal activities include designing, development and manufacture of medical drug delivery devices and services for the pharmaceutical industry. The Company operates through two segments: Bespak and Aesica. Bespak’s core business is the manufacture of inhaled drug delivery devices for life sciences partners and its operations are based in the United Kingdom. The Aesica business manufactures and sells active pharmaceutical ingredients (API), formulated pharmaceutical products and packaging services to the pharmaceutical industry and its operations are based in the United Kingdom and Europe. It offers its services to customers, such as pharmaceutical companies and life sciences. Its device products include metered dose inhalers, dry powder devices, actuators, dose counters, disposable auto-injectors, nasal devices and point-of-care diagnostics devices.

Receive News & Ratings for Consort Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Consort Medical and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply